Inhaled insulin Afrezza has launched in India, offering a needle-free option for diabetes management. Designed to overcome ...

Inhaled insulin, a patient-friendly alternative to injections, has been introduced in India. This new method aims to alleviate 'needle phobia' and improve diabetes management.

India’s Cipla Limited (BSE: 500087) announced the launch of Afrezza (insulin human) Inhalation Powder in India.

MannKind closed 2025 on a high note, marked by milestones that reinforce our growth trajectory—including the acquisition of scPharmaceuticals and a record-setting fourth quarter surpassing $100 ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 5 includes Hormel Foods, Hut 8, IonQ, Kodiak AI, ...

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

Yahoo College & High School Sports is powered by On3, delivering expert recruiting, NIL, and transfer portal news. Type 2 diabetes occurs when the body does not use insulin effectively or does not ...

Investing.com -- MannKind Corporation (NASDAQ:MNKD) stock surged 10.9% Thursday after the company outlined several potential growth catalysts for 2026, including multiple FDA decisions and new product ...

SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...